Market revenue in 2023 | USD 277.9 million |
Market revenue in 2030 | USD 436.4 million |
Growth rate | 6.7% (CAGR from 2023 to 2030) |
Largest segment | Anti-bacterial |
Fastest growing segment | Anti-fungal |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-bacterial, Anti-fungal, Corticosteroids, Others (Acaricidals, Cyclosporins) |
Key market players worldwide | Zoetis, Elanco Animal Health Inc, Dechra Pharmaceuticals, Merck & Co Inc, Vetoquinol SA, Virbac SA, CEVA Inc, Penn Veterinary Supply Inc, Vedco |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to companion animal ear infection treatment market will help companies and investors design strategic landscapes.
Anti-bacterial was the largest segment with a revenue share of 44.04% in 2023. Horizon Databook has segmented the U.S. companion animal ear infection treatment market based on anti-bacterial, anti-fungal, corticosteroids, others (acaricidals, cyclosporins) covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing number of pet owners and rising awareness about animal health & hygiene are expected to accelerate market growth. According to a survey conducted by the American Pet Products Association's National Pet Owners Survey, in 2021, 90.5 million U.S. families own a pet.
Hence, increasing pet ownership, along with improvements in R&D activities regarding animal healthcare are expected to fuel the market. For example, Dechra Pharmaceuticals spent almost USD 40.31 million on R&D in 2020 and USD 35.62 million in 2019.
The humanization of pets further drives the market across the country. The rising prevalence of ear infections in companion animals is one of the major factors contributing to market growth. Ear infection is the second-most common condition in canines.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. companion animal ear infection treatment market , including forecasts for subscribers. This country databook contains high-level insights into U.S. companion animal ear infection treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account